| Date | Title | Description |
| 13.03.2025 | Neuromod's €10M Financing: A New Dawn for Tinnitus Treatment | In the world of medical technology, innovation is the lifeblood. Neuromod Devices Ltd., a Dublin-based company, has just injected a fresh dose of vitality into the tinnitus treatment landscape. With a recent €10 million ($10.9 million) equi... |
| 13.03.2025 | Neuromod: €10 Million Closed For Tinnitus Treatment Device Commercialization | Neuromod Devices, an Irish medical device company specializing in tinnitus, announced it has closed a €10 million equity financing round to expand the availability of its tinnitus treatment device, Lenire. The equity funding is an expansion... |
| 12.03.2025 | Irish company Neuromod scores $10.9M for tinnitus medical device | Photo: martin-dm/Getty Images
Neuromod, a medical device company out of Dublin focused on treating tinnitus, secured €10 million ($10.9 million) in equity financing, expanding its Series B raise.
The raise builds on the company's €10.5 mill... |
| 11.03.2025 | Neuromod Closes €10M Financing | Neuromod Founder & CEO, Dr. Ross O’Neill with FDA Approved Tinnitus Treatment Device, Lenire
Neuromod Devices Ltd., a Dublin, Ireland-based medical device company specialising in tinnitus, closed a €10m equity financing in an expansion ... |
| 03.07.2024 | Neuromod Devices Ltd. Appoints Tom Maher as General Counsel | Tom Maher joins Neuromod Devices Ltd. with more than twenty-five years of corporate legal and business experience in the international life sciences industry, including biopharma, biotech, and medtech.
DUBLIN, July 3, 2024 /PRNewswire/ -- N... |
| 09.05.2024 | 10 Irish startups to watch in 2024 | Amidst a rapidly evolving technology landscape, Irish technology companies have demonstrated their power in solutions that have not only pushed the boundaries of innovation but also cemented their position as key players on the global stage... |
| 14.04.2023 |
Neuromod Devices Closes €30 Million Financing to Expand Availability of Tinnitus Treatment Device Lenire® | Equity investment led by Panakès Partners with venture debt provided by European Investment Bank
Financing round follows recent US FDA granting of De Novo approval to Neuromod's Lenire tinnitus treatment device
Neuromod Devices Ltd, an ... |
| 13.04.2023 | Dublin-based medtech firm Neuromod Devices bags €30M to accelerate availability of Tinnitus treatment device | Dublin-based Neuromod Devices, a medtech company that specialises in neuromodulation, announced on Thursday that it has secured €30M in a Series B round of funding.
Out of the total, €15M of equity investment was led by Panakès Partners. Th... |
| 13.04.2023 | Neuromod Devices closes €30m financing for tinnitus treatment | Irish medical device company Neuromod Devices Ltd has closed a €30m financing to further commercialise its tinnitus treatment device, Lenire.
The device has shown in large-scale clinical trials that it can reduce the severity of tinnitus, w... |
| 13.04.2023 | Neuromod Devices Closes €30M Financing | Woman using Lenire Tinnitus Treatment device
Neuromod Devices, a Dublin, Ireland-based medical device company, raised €30M in funding.
The €15m Series B equity round was led by Panakès Partners, with participation from Fountain Healthcare P... |
| 13.04.2023 | Neuromod Devices closes €30m financing for tinnitus treatment | Irish medical device company Neuromod Devices Ltd has closed a €30m financing to further commercialise its tinnitus treatment device, Lenire.
The device has shown in large-scale clinical trials that it can reduce the severity of tinnitus, w... |
| 13.04.2023 |
Neuromod Devices closes $33.2M financing for tinnitus-treating neuromodulation tech | A woman using the Lenire neuromodulation device. [Image courtesy of Neuromod Devices]Neuromod Devices announced today that it closed a $33.2 million (€30 million) financing round to support its tinnitus treatment device.
Dublin, Ireland–bas... |
| 07.03.2023 |
FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval | Neuromod Devices' non-invasive device, Lenire, is the first of its kind granted approval to treat tinnitus in the US market.
At least 25,000,000 Americans are suffering from tinnitus, 2,700,000 are veterans.
FDA approval based on results ... |
| 30.06.2022 | Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms | - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire®
- 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months af... |
| 06.04.2022 |
Neuromod establishes global commercial leadership team |
Neuromod Devices Ltd. has announced the formation of a global commercial leadership team to direct the commercialisation of its Lenire tinnitus treatment device through key partnerships.
The establishment of the team sees the organisatio... |
| 21.02.2022 | Tinnitus device maker Neuromod cheered by German study results | Medical device company Neuromod has welcomed the findings of a study by Germany Hearing Centre (DHZ) at Hannover Medical School, which found that 85% of tinnitus patients experienced a reduction in their symptoms when using its Lenire treat... |
| 13.07.2021 |
Neuromod research reveals that more than three in four UK tinnitus sufferers have never received treatment for their condition | New research from Irish medical device company, Neuromod Devices Ltd, has found that more than three quarters of people suffering from tinnitus in the United Kingdom have never received any treatment for their condition. The poll also revea... |
| 21.10.2020 | Daily funding roundup - October 20th, 2020 | Quake landed $2.5M; Index raised 2.6M; Decentriq secured 3.8M; Vectary picks up $7.3M
YPC Technologies: YPC Technologies is a Montreal, Quebec-based company at work on kitchen robotics technologies. YPC Technologies has raised $1.8 million ... |
| 20.10.2020 | Neuromod Raises €10.5m For Tinnitus Device | Medical devices company Neuromod has raised €10.5m in a Series B fundraiser, led by majority investor Fountain Healthcare Partners.
Founded by Dr Ross O’Neill in 2010 to develop new technologies for the treatment of neurological conditions,... |
| 20.10.2020 | Neuromod Closes €10.5M Series B Financing | Neuromod Devices Limited, a Dublin, Ireland-based medical device company specializing in the treatment of tinnitus, raised €10.5m in Series B financing.
The round was led by majority investor Fountain Healthcare Partners, with participation... |
| 20.10.2020 | Dublin-based Neuromod Raises €10.5M in Series B Financing | - |
| 27.09.2019 | Neuromod Closes €8M in Funding | Neuromod Devices, a Dublin, Ireland-based medical technology company specializing in non-invasive neuromodulation technologies, closed an €8m in equity and venture-debt funding.
The round was led by existing investors Fountain Healthcare Pa... |
| 30.09.2015 | Neuromed Raises €5.5 Million | Neuromod Devices has raised €5.5 million in Series A Funding from Fountain Healthcare Partners to advance its chronic tinnitus treatment.
The Irish medical device company has developed Mutebutton to treat tinnitus. The investment will be us... |
| 29.09.2015 | Neuromod Devices Raises €5.5M in Series A Funding | Neuromod Devices Limited, a Dublin, Ireland-based medical device company specializing in the treatment of chronic tinnitus, raised €5.5m (approx. $6.2m) in Series A funding.
International life sciences venture capital fund Fountain Healthca... |
| 12.12.2014 | Neuromod To Hire 50 After Mutebutton Launch | NUI Maynooth spin-out Neuromod Devices is to hire 50 staff over the next five years, following the launch of the firm’s new treatment for tinnitus.
Based in NovaUCD, Neuromod was founded by Dr Ross O'Neill in 2010 to develop new technologie... |
| - | Neuromod Devices | “Neuromod Devices is an ambitious, forward-looking medical technology company formed to advance the science of neuromodulation, we named ourselves Neuromod in the shared belief of what this cutting edge branch of medicine can achieve.” |
| - | Neuromod Devices Raises €30 Million To Commercialize Its Tinnitus Treatment Device Lenire | Neuromod Devices – an Irish medical device company specializing in neuromodulation – announced it has successfully closed a €30 million financing to further commercialize its tinnitus treatment device Lenire. Tinnitus is commonly referred t... |
